Follow
Nikolai Eroshenko
Nikolai Eroshenko
HelixNano
Verified email at helixnano.com
Title
Cited by
Cited by
Year
Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips
S Kosuri, N Eroshenko, EM LeProust, M Super, J Way, JB Li, GM Church
Nature biotechnology 28 (12), 1295-1299, 2010
3762010
Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures
N Eroshenko, T Gill, MK Keaveney, GM Church, JM Trevejo, H Rajaniemi
Nature biotechnology 38 (7), 789-791, 2020
1572020
Effect of substrate stiffness on early human embryonic stem cell differentiation
N Eroshenko, R Ramachandran, VK Yadavalli, RR Rao
Journal of biological engineering 7, 1-8, 2013
1372013
Mutants of Cre recombinase with improved accuracy
N Eroshenko, GM Church
Nature communications 4 (1), 2509, 2013
432013
Role of bioinspired polymers in determination of pluripotent stem cell fate
S Abraham, N Eroshenko, RR Rao
Regenerative medicine 4 (4), 561-578, 2009
382009
Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors
S Iyer, E Xiao, K Alsayegh, N Eroshenko, MJ Riggs, JP Bennett, RR Rao
Gene therapy 19 (5), 469-475, 2012
312012
Gene Assembly from Chip‐Synthesized Oligonucleotides
N Eroshenko, S Kosuri, AH Marblestone, N Conway, GM Church
Current protocols in chemical biology 4 (1), 1-17, 2012
262012
Orthogonal amplification and assembly of nucleic acid sequences
GM Church, S Kosuri, N Eroshenko
62012
Modified ribonucleic acids and uses thereof
N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn
US Patent App. 18/451,322, 2024
2024
Modified ribonucleic acids and uses thereof
N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn
US Patent App. 18/451,386, 2023
2023
Acetylated ribonucleic acids and uses thereof
N Dhar, K Backman, DJD Pasillas, JS Huang, N Eroshenko
US Patent App. 18/143,533, 2023
2023
Compositions including SBI adjuvants and methods of use thereof
K Backman, N Dhar, N Eroshenko, T Gill, K Jammeh, M Keaveney, ...
US Patent 11,771,758, 2023
2023
Compositions comprising alpha-factor prepro sequence and uses thereof
T Gill, K Jammeh, N Eroshenko
US Patent App. 18/093,805, 2023
2023
Modified ribonucleic acids and uses thereof
N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn
US Patent App. 18/075,085, 2023
2023
Linear covalently closed vectors and related compositions and methods thereof
N Eroshenko, N Dhar
US Patent App. 17/897,498, 2023
2023
Modified ribonucleic acids and uses thereof
N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn
US Patent 11,639,501, 2023
2023
Linear covalently closed vectors and related compositions and methods thereof
N Eroshenko, N Dhar
US Patent 11,473,090, 2022
2022
METHODS AND COMPOSITIONS FOR NUCLEIC ACID EXPRESSION INVOLVING INHIBITION of NF-kB PATHWAYS AND/OR IRF PATHWAYS
N Eroshenko, H Rajaniemi, N Dhar
US Patent App. 17/163,168, 2021
2021
Compositions and methods for rna synthesis
N Dhar, N Eroshenko, H Rajaniemi
US Patent App. 17/246,451, 2021
2021
Methods and compositions for rna expression of myc inhibitors
N Eroshenko, N Dhar, T Gill, M Keaveney, H Rajaniemi
US Patent App. 17/269,787, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20